Clinical trial · Observational
Facial Skin Health Tracking Feasibility in Breast Cancer Patients
Tracking the Natural History of Facial Skin Health in Pre and Peri Menopausal Breast Cancer Patients Undergoing Chemotherapy and / or Endocrine Therapies: A Feasibility Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Low/No Accrual
Summary
Brief summary (as posted)
This feasibility study will assess if tracking objective and subjective facial skin changes over time is acceptable to pre and perimenopausal women undergoing chemotherapy and/or endocrine therapy for breast cancer. There is no intervention arm and no control group. Skin health will be assessed through the instruments described below, and subjective data will be collected with self-administered questionnaires.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Female | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Skin health assessment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- All subjects
- description
- All the enrolled subjects will be considered for the assessment of the primary and secondary outcomes.
- interventionNames
- Other: Skin health assessment
Primary outcomes (1)
- measure
- Percentage of compliance in each of the 4 assessment tools
- timeFrame
- 3 years
- description
- defined as the percentage of patients completing all the scheduled assessments under each assessment tool. The percentage of compliance will be summarized and the associated 90% confidence interval reported. If the percentage of compliance is 80% or higher under each assessment tool, the study will be considered feasible.
Secondary outcomes (2)
- measure
- Changes in skin health over the duration of the study (4 assessment points)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Provision to sign and date the consent form 2. Stated willingness to comply with all study procedures and be available for the duration of the study 3. Be a pre or perimenopausal woman age 18 or over 4. Be a patient with a new diagnosis of breast cancer who plans to undergo systemic chemotherapy or endocrine therapy, but who has not yet started treatment Exclusion Criteria: 1. Postmenopausal status (one year without a menstrual period) 2. Pregnant women (pregnancy test not required) 3. Prior cancer diagnosis of any type other than breast cancer 4. History of prior treatment with chemotherapy or radiation therapy 5. Chronic skin disease including scleroderma, discoid lupus, atopic dermatitis, rosacea, eczema, or psoriasis 6. Use of a retinoid-based prescription facial skin product within the past 11 month
References
Publications (0)
Data not yet available